Supportive Care News & Features

Patients Prefer Physicians Conveying Positivity

Patients Prefer Physicians Conveying Positivity

Patients prefer physicians who convey a more optimistic message, and perceive in them a higher level of compassion.

Legal Challenges Begin for Biosimilar Agents

Legal Challenges Begin for Biosimilar Agents

As key biologics near the end of their patent-protection periods, industry is preparing for legal battles over biosimilar versions.

Presenteeism May Be a Problem for Oncologists and, Ultimately, Their Patients

Presenteeism May Be a Problem for Oncologists and, Ultimately, Their Patients

Research highlights how lack of guidelines regarding illness and adequate staffing at hospitals may be reason for oncologists working while sick.

Hospice Care for Patients with Advanced Cancer Has Significant Impact on Quality of Life

Hospice Care for Patients with Advanced Cancer Has Significant Impact on Quality of Life

Patients enrolled in hospice care had lower rates of healthcare utilization, and their costs for care were less during their last year of life.

Worse Quality of Life for Older Patients with Multiple Myeloma, Pancreatic Cancer

Worse Quality of Life for Older Patients with Multiple Myeloma, Pancreatic Cancer

Poor health outcomes for many survivors, especially survivors of multiple myeloma, pancreatic cancer.

More in Supportive Care

Nurses Collaborate to Facilitate Shared Decisions on Palliative Sedation

Nurses Collaborate to Facilitate Shared Decisions on Palliative Sedation

ANAHEIM, CALIFORNIA—A multidisciplinary approach that also heavily incorporates input from patients and their families helped alleviate concerns about inappropriate use of palliative sedation and improved patient-centered care, a speaker said at the Oncology Nursing Society (ONS) 39th Annual Congress.

Pain Remains Prevalent in Ambulatory Cancer

Pain Remains Prevalent in Ambulatory Cancer

Inadequate pain management, baseline pain severity linked to pain deterioration

Duloxetine Effective at Reducing Chemotherapy Pain

Duloxetine Effective at Reducing Chemotherapy Pain

Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.

Opioid Prescriptions Underprescribed for Severe Pain in Elderly Patients with Cancer

A Canadian study has identified factors associated with opioid prescriptions for severe pain in the elderly: younger age, male sex, comorbid illness, type of cancer, and assessment at home, results of a study in the Journal of Clinical Oncology published online February 27 has found.

Intrathecal Therapy Cost-Effective for Patients with Cancer Pain Who Have a Favorable Life-Expectancy

In selected patients with cancer pain on high-cost conventional regimens, intrathecal therapy may become cost-effective as early as seven months following implant, and greater duration of therapy is associated with reduced costs.

Understanding End-of-Life Care Among Adolescents, Young Adults with Cancer

Understanding End-of-Life Care Among Adolescents, Young Adults with Cancer

Most adolescents and young adults (AYAs) with cancer received medically intensive end-of-life (EOL) care measures.

Examining Advance Care Planning's Role in End-of-Life Care Decisions

Examining Advance Care Planning's Role in End-of-Life Care Decisions

Between 2000 and 2012, use of durable power of attorney increased significantly but no association established with end-of-life care decisions.

Experts Form Consensus on Indicators of Integration of Oncology, Palliative Care Programs

Experts Form Consensus on Indicators of Integration of Oncology, Palliative Care Programs

International experts reached consensus on the makeup of integration of oncology and palliative care.

Early Palliative Care Linked with Lower Hospital Cost

Early Palliative Care Linked with Lower Hospital Cost

Earlier palliative care consultation is associated with lower cost of hospital stay for patients with advanced cancer.

Gender Disparity in Receipt of End-of-Life Care

Gender Disparity in Receipt of End-of-Life Care

There are gender differences in receipt of end-of-life (EoL) care among terminally ill cancer patients.

Self-reported Measures May Accurately Identify Cancer-Related Fatigue

Self-reported Measures May Accurately Identify Cancer-Related Fatigue

Brief screening indices derived from self-report fatigue measures can accurately identify cancer-related fatigue in breast cancer.

Many Carers of Patients Newly Diagnosed with Cancer at Risk for Depression

Many Carers of Patients Newly Diagnosed with Cancer at Risk for Depression

Most carers of people with newly diagnosed cancer reported at least one unmet need and nearly a third were at risk of clinical depression.

Fatigue in Patients with Advanced Cancer Not Improved by Oral Melatonin

Fatigue in Patients with Advanced Cancer Not Improved by Oral Melatonin

No differences in physical fatigue, secondary outcomes, or explorative outcomes observed between oral melatonin and placebo periods.

Incidence, Predictors of Diastolic Dysfunction Post-Anthracyclines in Breast Cancer

Incidence, Predictors of Diastolic Dysfunction Post-Anthracyclines in Breast Cancer

Clinicians may have a better way to identify patients at higher risk for developing a clinically relevant anthracycline cardiotoxicity.

Identifying Lymphoma Survivors at Higher Risk for LVSD, Heart Failure

Identifying Lymphoma Survivors at Higher Risk for LVSD, Heart Failure

Researchers may have found a way to identify adult lymphoma survivors at increased risk for left ventricular systolic dysfunction (LVSD).

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs